Lv4
749 积分 2023-03-30 加入
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
6天前
已关闭
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
16天前
已完结
Current state and challenges in respiratory syncytial virus drug discovery and development
17天前
已完结
Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models
18天前
已完结
Effectiveness and safety of combined dupilumab and risankizumab in concomitant atopic dermatitis and psoriasis
23天前
已完结
Combining TNF-α Inhibitors with IL-4, IL-17, IL-23, or JAK Inhibitors in Patients with Multiple, Severe Dermatologic Conditions and/or Gastrointestinal or Rheumatologic Disease
23天前
已完结
Combined use of Omalizumab and dupilumab: safety and efficacy data from a large academic center
23天前
已完结
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
23天前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
23天前
已完结
Atopic dermatitis
24天前
已完结
皖公网安备34019202002308
